Join the club for FREE to access the whole archive and other member benefits.

Investments News

Exeters' company SENISCA raises £2 million to treat age-related chronic diseases

University of Exeter - 09-Jun-2022

Funding might allow RNA-based rejuvenation tech to enter ex vivo lab tests

Read more...

Hevolution Foundation to spend $1 billion annually on the biology of aging

MIT Technology Review - 07-Jun-2022

Considering funding a $100 million age reversal X Prize and the TAME(metformin) trial

Read more...

Insilico Medicine series D funding to grow its pipeline and create an AI-driven robotic drug discovery laboratory

Longevity Technology - 06-Jun-2022

Big data combined with laboratory automation - the pace of drug discovery is about to take off!

Read more...

Selah Therapeutics launched to focus on ketone-based therapies for heart disease

Longevity Technology - 13-May-2022

Treatment options for diseases of aging - from the makers of metabolic switch

Read more...

New longevity startup MitoRx Therapeutics is developing mitochondria protective drugs

Longevity Technology - 25-Apr-2022

Targeting age-related diseases, the company's pre-clinical compounds to progress to the clinic

Read more...

CARMAT raised €40.5 million - set to resume the artificial heart production

Longevity Technology - 21-Apr-2022

Aeson could prolong lives of patients awaiting a human heart transplant

Read more...

Satellite Bio raised $110M to push its tissue therapies to the clinic

FierceBiotech - 20-Apr-2022

Bioengineered implanatable tissues can repair or replace diseases organs

Read more...

YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO

CISION PR Newswire - 14-Apr-2022

Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line

Read more...

Turn Bio raised funds to usher epigenetic reprogramming from bench to bedside

Biospace - 11-Apr-2022

mRNA technology-reset aging to extend health span and improve quality of life

Read more...

Elastrin Therapeutics secures $10 million of funding for its calcification removal platform

Forever Healthy Foundation - 07-Apr-2022

Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications

Read more...

Retro Biosciences launched to add 10 years to human lifespan

Biospace - 06-Apr-2022

$180M fund will support research on cellular reprogramming, autophagy & plasma-inspired therapeutics

Read more...

Revel pharmaceutics raised $8.4M to push enzyme therapies to clinic

KIZOO Technology Ventures - 17-Mar-2022

Funds will be used to develop enzymes that repair collagen and reverse ageing or disease

Read more...

Tornado, new longevity biotech developing safer and effective mTOR inhibitors

Longevity Technology - 03-Mar-2022

Different flavours of rapalogs targeting different age-related conditions

Read more...

Maximon announces 50,000 CHF (approx. £40K) Longevity Prize for Translational Research

Maximon - 01-Mar-2022

And by longevity it means "substantially increase health span or life span" - apply now!

Read more...

Synchron gets investment from Neuralink cofounder

Futurism - 07-Feb-2022

Appears to be ahead in the race as already started human trials

Read more...

Hair grown from your own cells may treat baldness

New Atlas - 06-Feb-2022

dNovo converts any cell to hair stem cells, and have already grown hair in mice

Read more...

Arda Therapeutics, new biotech startup aims to delay or reverse disease progression

Lifespan.io (LEAF) - 28-Jan-2022

Tailoring strategies to eliminate bad cells in age-related diseases

Read more...

Cellino Biotech raises $80m to upscale its automated stem cell production

TechCrunch - 25-Jan-2022

Fast, cheap and plentiful iPSCs will be needed for clinical trials and new treatments

Read more...

Altos Labs comes out of stealth with $3 billion of capital

Genetic Engineering & Biotechnology News (GEN) - 19-Jan-2022

Huge backing that cellular reprogramming can have a significant impact on health and ageing

Read more...

StarkAge receives 2 million euros to design safer senescence-targeted therapies

Longevity Technology - 19-Jan-2022

Funding will ensure the development of a new immunotherapy for age-related diseases

Read more...

DKG profile interview with its own Remus Stanescu, Director of Longevity Financial Advisors

Deep Knowledge Group - 12-Jan-2022

Highlights some nuances when investing in the longevity industry

Read more...

Genflow IPO listing: the first longevity firm to debut on London Stock Exchange

Longevity Technology - 10-Jan-2022

Seeking funds to develop gene therapies that target ageing in humans and dogs

Read more...

Life Biosciences raises funding to develop innovative therapies against ageing biology

Longevity Technology - 06-Jan-2022

Invests $82 million in research platforms, aiming to prevent or reverse age-related diseases

Read more...

NewLimit, a new biotech launches to slowdown or reverse ageing

NewLimit - 12-Dec-2021

Aims to extend healthspan and cure ageing with affordable epigenetic therapies

Read more...

Spring discovery to prevent diseases by developing treatments for ageing

Medium - 11-Dec-2021

Raised $18 million Series A funding to speed up ageing research

Read more...

Display all news